معرفی
Elana Rosenthal, MD is an Associate Professor in the Department of Medicine at the University of Maryland School of Medicine. She serves as Associate Chief of Clinical Research and Co-Director of the Research Initiative on Infectious Disease and Substance Use (RIIS), focusing on integrated care models for vulnerable populations.
Her educational background includes:
- BA from Yale University (2006)
- MD from University of Chicago Pritzker School of Medicine (2010)
- Internal Medicine Residency at Beth Israel Deaconess Medical Center (2013)
- Infectious Diseases Fellowship at Beth Israel Deaconess Medical Center (2015)
Dr. Rosenthal's research centers on the intersection of substance use disorder and infectious diseases, with specialized focus on gender/sexual minorities and incarcerated populations. Her work addresses critical gaps in care for people who inject drugs (PWID), particularly regarding HIV/HCV coinfection and opioid use disorder treatment access. She conducts community-based research in Washington, DC and Baltimore clinical sites, emphasizing real-world implementation of evidence-based interventions.
Analysis of her 15 most recent publications (2017-2023) reveals evolving research priorities: early work focused on HCV treatment access barriers for PWID, progressing to integrated OUD/HCV treatment models, PrEP implementation, and stigma reduction. Her recent studies increasingly examine health equity dimensions, including gender disparities and structural barriers in correctional settings. Methodologically, she employs clinical trials, observational studies, and policy analyses to advance harm reduction frameworks.
As Co-Director of RIIS, she leads multidisciplinary teams developing low-threshold interventions for substance-using populations with infectious comorbidities. Her administrative role as Associate Chief of Clinical Research involves overseeing institutional research infrastructure while maintaining active community-based clinical practice.
